Raynovent Funding: $54M Raised, Series C (2023)

Raynovent is based in Guangzhou, China. It has raised $54M in total funding. Latest round: Series C. Backed by Efung Capital, Yide Fund.

Raynovent funding overview

Raynovent is based in Guangzhou, China. Raynovent has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2023. The round record for Raynovent runs through 2023; nothing later has been disclosed. Investors on record include Efung Capital, Yide Fund. 2 distinct backers are named across the disclosed rounds.

Raynovent at a glance

Total raised
$54M
Latest round
Series C
Latest round date
January 2023
Headquarters
Guangzhou, China
Notable investors
Efung Capital, Yide Fund

Frequently asked about Raynovent funding

How much has Raynovent raised?
Raynovent has raised $54M in total disclosed funding across the rounds on record.
Who has invested in Raynovent?
Efung Capital, Yide Fund are named among the investors backing Raynovent.
What was the latest Raynovent funding round?
The most recent disclosed round is a Series C, announced in January 2023.
Where is Raynovent based?
Raynovent is based in Guangzhou, China.
When did Raynovent last raise?
The last disclosed Raynovent round closed in January 2023 at Series C.

We update the Raynovent record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Guangzhou and their backers are listed below.

Companies related to Raynovent (23)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026